Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells

Mol Cell Biol. 1999 Aug;19(8):5326-38. doi: 10.1128/MCB.19.8.5326.

Abstract

One of the major actions of interleukin-6 (IL-6) is the transcriptional activation of acute-phase plasma proteins (APP) genes in liver cells. Signaling by the IL-6 receptor is mediated through the signal transducing subunit gp130 and involves the activation of Janus-associated kinases (JAKs), signal transducer and activator of transcription 3 (STAT3), and mitogen-activated protein (MAP) kinase. Functional analysis of gp130 in rat hepatoma cells by using transduced chimeric G-CSFR-gp130 receptor constructs demonstrates that SHP-2, the Src homology 2 (SH2) domain-containing protein tyrosine phosphatase, acts as a negative regulator of the JAK/STAT signaling in part by downregulating JAK activity, thereby indirectly moderating the induction of STAT3-dependent APP genes. This study shows that in hepatoma cells, the recruitment and tyrosine phosphorylation of SHP-2, but not SHC, is the primary signaling event associated with the activation of MAP kinases (ERK1/2) by gp130. Overexpression of truncated SHP-2 that lacks Grb2-interacting sites, but not the full-length catalytically inactive SHP-2, reduces ERK activation by IL-6, confirming the signal-mediating role of SHP-2. Activation of ERK1/2 is correlated with induction of the immediate-early response genes. Stimulation of the c-fos, c-jun, and egr-1 genes is essentially absent in cells expressing gp130 with a Y759F mutation, which is unable to recruit SHP-2. Interestingly, both JAK/STAT and SHP-2 pathways regulate the induction of the junB gene. Moreover, disengagement of SHP-2 from gp130 signaling not only enhances APP gene induction but also further reduces cell proliferation, in part correlated with the attenuated expression of immediate-early response genes. These results suggest that IL-6 regulation of APP genes is affected by SHP-2 in two ways: SHP-2 acts as a phosphatase on the JAK/STAT pathway and serves as linker to the MAP kinase pathway, which in turn moderates APP production.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute-Phase Proteins / biosynthesis*
  • Acute-Phase Proteins / genetics
  • Acute-Phase Reaction / genetics*
  • Adaptor Proteins, Signal Transducing*
  • Animals
  • Antigens, CD / physiology
  • Calcium-Calmodulin-Dependent Protein Kinases / physiology
  • Carcinoma, Hepatocellular / genetics
  • Carcinoma, Hepatocellular / metabolism
  • Carcinoma, Hepatocellular / pathology
  • Cytokine Receptor gp130
  • DNA-Binding Proteins / physiology
  • Enzyme Activation
  • GRB2 Adaptor Protein
  • Gene Expression Regulation*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Interleukin-6 / physiology*
  • Intracellular Signaling Peptides and Proteins
  • Janus Kinase 1
  • Liver / drug effects
  • Liver / metabolism*
  • Liver Neoplasms / genetics
  • Liver Neoplasms / metabolism
  • Liver Neoplasms / pathology
  • Liver Neoplasms, Experimental / genetics
  • Liver Neoplasms, Experimental / metabolism
  • Liver Neoplasms, Experimental / pathology
  • Membrane Glycoproteins / physiology
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases*
  • Neoplasm Proteins / biosynthesis
  • Neoplasm Proteins / genetics
  • Phosphorylation
  • Protein Processing, Post-Translational
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6
  • Protein Tyrosine Phosphatases / physiology*
  • Protein-Tyrosine Kinases / physiology
  • Proteins / metabolism
  • Rats
  • Receptors, Interleukin-6 / drug effects
  • Receptors, Interleukin-6 / physiology*
  • Recombinant Fusion Proteins / physiology
  • SH2 Domain-Containing Protein Tyrosine Phosphatases
  • STAT3 Transcription Factor
  • Signal Transduction / physiology*
  • Trans-Activators / physiology
  • Transcription, Genetic
  • Transcriptional Activation
  • Transfection

Substances

  • Acute-Phase Proteins
  • Adaptor Proteins, Signal Transducing
  • Antigens, CD
  • DNA-Binding Proteins
  • GRB2 Adaptor Protein
  • GRB2 protein, human
  • Grb2 protein, rat
  • IL6ST protein, human
  • Il6st protein, rat
  • Interleukin-6
  • Intracellular Signaling Peptides and Proteins
  • Membrane Glycoproteins
  • Neoplasm Proteins
  • Proteins
  • Receptors, Interleukin-6
  • Recombinant Fusion Proteins
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Stat3 protein, rat
  • Trans-Activators
  • Cytokine Receptor gp130
  • Protein-Tyrosine Kinases
  • JAK1 protein, human
  • Jak1 protein, rat
  • Janus Kinase 1
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • PTPN11 protein, human
  • PTPN6 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6
  • Protein Tyrosine Phosphatases
  • Ptpn11 protein, rat
  • Ptpn6 protein, rat
  • SH2 Domain-Containing Protein Tyrosine Phosphatases